Dual nano‐sized contrast agents in PET/MRI: a systematic review

Abstract

Nowadays molecular imaging plays a vital role in achieving a successful targeted and personalized treatment. Hence, the approach of combining two or more medical imaging modalities was developed. The objective of this review is to systematically compare recent dual contrast agents in Positron Emission Tomography (PET)/Magnetic Resonance Imaging (MRI) and in some cases Single photon emission computed tomography (SPECT)/MRI in terms of some their characteristics, such as tumor uptake, and reticuloendothelial system uptake (especially liver) and their relaxivity rates for early detection of primary cancer tumor. To the best of our knowledge, this is the first systematic and integrated overview of this field. Two reviewers individually directed the systematic review search using PubMed, MEDLINE and Google Scholar. Two other reviewers directed quality assessment, using the criteria checklist from the CAMARADES (Collaborative Approach to Meta-Analysis and Review of Animal Data from Experimental Studies) tool, and differences were resolved by consensus. After reviewing all 49 studies, we concluded that a size range of 20-200 nm can be used for molecular imaging, although it is better to try to achieve as small a size as it is possible. Also, small nanoparticles with a hydrophilic coating and positive charge are suitable as a T contrast agent. According to our selected data, the most successful dual probes in terms of high targeting were with an average size of 40 nm, PEGylated using peptides as a biomarker and radiolabeled with copper 64 and gallium 68. Copyright © 2017 John Wiley & Sons, Ltd.

Simultaneous in vivo PET/MRI using fluorine-18 labeled Fe3O4@Al(OH)3 nanoparticles: comparison of nanoparticle and nanoparticle-labeled stem cell distribution

“…Overcoming disadvantages of single modality imaging may also require the use of dual contrast agents in multimodal approaches, e.g., simultaneously acquired PET/MRI. Combining PET and MRI not only provides anatomical images with great soft tissue contrast (MRI), but also highly sensitive and specific functional, cellular (PET and MRI), and molecular images with low background (PET) depending on the radiotracer used [25,26]. While the time period that a tracer can be followed in vivo using PET is restricted and depends on the radionuclide's half-life, MRI allows long-term detection of dual contrast agents.…”

“…While the time period that a tracer can be followed in vivo using PET is restricted and depends on the radionuclide's half-life, MRI allows long-term detection of dual contrast agents. Furthermore, simultaneous PET/ MRI acquisition facilitates the image co-registration of both modalities [26].…”

Iron Oxide Nanoradiomaterials: Combining Nanoscale Properties with Radioisotopes for Enhanced Molecular Imaging

“…These ligands, also known as DOTA or NOTA, present tetra or triacetic acids that form a very stable coordination complex with different radioisotopes such as 64 Cu or 68 Ga. Macrocyclic ligands are preferred because they present slower dissociation rates than their linear analogous [ 134 ]. Examples with this approach have been described for SPECT/MRI or PET/MRI [ 135 , 136 ]. Concerning SPECT/MRI, 99m Tc is the most used radioisotope.…”

A Systematic Review and Critical Analysis of the Role of Graphene-Based Nanomaterials in Cancer Theranostics

“…As each strategy has inherent advantages and limitations, the combination of complementary strategies can result in a synergic theranostic effect. Tables S1, S2 and S3 (Supplementary material) summarize some of the most important therapeutic strategies (drug and gene therapy, phototherapy (PTT), magnetic hyperthermia (MHT), and photodynamic therapy (PDT)), and diagnostic strategies (therapy guiding by fluorescence imaging (FI), two photon fluorescence imaging (2PFI), infrared thermal imaging (IR-TI), Raman imaging, X-ray imaging, magnetic resonance imaging (MRI), positron emission tomography (PET), single-photon emission computed tomography (SPECT), computed tomography (CT), photoacoustic imaging (PAI), and ultrasound imaging (USI)) that are being used in nanotheranostic systems [9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24].…”